Bidentate Ligands That Contain Pyrrole
Inorganic Chemistry, Vol. 39, No. 3, 2000 589
8-Quinolylhydrazone of 3-acetylpyridine (13c). Following the
procedure described for 13b, a mixture of 3-acetylpyridine (0.60 g, 5
mmol) and 8-hydrazinoquinoline (0.80 g, 5 mmol) in absolute EtOH
(20 mL) was heated at reflux for 2 h to provide 13c as a yellow solid
The organic layer was washed with ammonium hydroxide and dried
over anhydrous Na2CO3. The solvent was evaporated to provide 15 as
a brown-red solid (62 mg, 61%): mp 224-227 °C; 1H NMR (DMSO-
d6) δ 8.65 (d, 1H, J ) 4.2 Hz, H8), 8.38 (d, 2H, J ) 6.0 Hz, H2′ and
H6′), 8.23 (d, 2H, J ) 6.0 Hz, H3′ and H5′), 8.05 (d, 1H, J ) 8.1 Hz,
H6), 7.55 (d, 1H, J ) 8.4 Hz, H4 or H5) 7.40 (s, 1H, H3), 7.26 (m, 1H,
H7), 7.03 (d, 1H, J ) 8.1 Hz, H4 or H5), 4.03 (s, 3H, CH3). Anal.
Calcd for C17H13N3‚CH2Cl2: C, 62.79; H, 4.36; N, 12.20. Found: C,
63.27; H, 4.76; N, 12.39.
[Ru(4a)(bpy-d8)2](PF6). A mixture of [Ru(bpy-d8)2Cl2] (54 mg, 0.1
mmol) and 2-(2′-pyridyl)-indole (4aH, 19 mg, 0.1 mmol) in EtOH/
H2O (3:1, 20 mL) was heated at reflux for 30 h under Ar. After the hot
reaction mixture was filtered, a solution of NH4PF6 (50 mg, 0.3 mmol)
in EtOH/H2O (3:1, 5 mL) was added to the filtrate. The solvent was
evaporated to produce a brown solid. The residue was purified by
chromatography on alumina (15 g). After unreacted 4aH was eluted
with CH2Cl2/hexanes (2:1), a following fraction, eluted with CH2Cl2,
was evaporated to produce the complex as a brown red solid (45 mg,
49%): 1H NMR (CD3CN) δ 8.00 (d, 1H, J ) 7.8 Hz, H3′), 7.69 (t, 1H,
J ) 7.8 Hz, H4′), 7.45 (d, 1H, J ) 8.1 Hz, H4), 7.33 (d, 1H, J ) 5.4
Hz, H6′), 7.18 (s 1H, H3), 6.88 (t, 1H, J ) 6.6 Hz, H5′), 6.67 (t, 1H, J
) 7.5 Hz, H5), 6.45 (t, 1H, J ) 7.5 Hz, H6), 5.36 (d, 1H, J ) 8.4 Hz,
H7); MS m/z 626 (M + 4+).
[Ru(4b)(bpy-d8)2](PF6). Following the procedure described for [Ru-
(4a)(bpy-d8)2](PF6), a mixture of 3-methyl-2-(2′-pyridyl)-indole (4bH,
32 mg, 0.15 mmol) and [Ru(bpy-d8)2Cl2] (80 mg, 0.15 mmol) in EtOH/
H2O (3:1, 20 mL) was heated at reflux for 15 h to afford the complex
as a brown red solid (51 mg, 43%): 1H NMR (CD3CN) δ 8.06 (d, 1H,
J ) 7.8 Hz, H3′), 7.72 (t, 1H, J ) 7.5 Hz, H4′), 7.44 (d, 1H, J ) 8.1
Hz, H4), 7.40 (d, 1H, J ) 5.4 Hz, H6′), 6.86 (t, 1H, J ) 6.9 Hz, H5′),
6.63 (t, 1H, J ) 7.5 Hz, H5), 6.44 (t, 1H, J ) 7.5 Hz, H6), 5.32 (d, 1H,
J ) 8.4 Hz, H7), 2.70 (s, 3H, CH3); MS m/z 640 (M + 4+).
[Ru(5a)(bpy-d8)](PF6). Following the procedure described for [Ru-
(4a)(bpy-d8)2](PF6), a mixture of 2-(2′-pyrrolyl)-quinoline (5aH, 39 mg,
0.2 mmol) and [Ru(bpy-d8)2Cl2] (107 mg, 0.2 mmol) in EtOH/H2O
(3:1, 20 mL) was heated at reflux for 24 h to afford the complex as a
brown red solid (29 mg, 19%): 1H NMR (CD3CN) δ 7.96 (d, 1H, J )
8.7 Hz, H4), 7.79 (d, 1H, J ) 8.7 Hz, H3), 7.65 (d, 1H, J ) 7.8 Hz,
H5), 7.19 (t, 1H, J ) 7.2 Hz, H6), 7.11-7.09 (m, overlapping, 2H, H8
and H3′), 7.01 (t, 1H, J ) 7.5 Hz, H7), 6.21 (m, 1H, H4′), 5.89 (s, 1H,
H5′); MS m/z 626 (M + 4+).
[Ru(5b)(bpy-d8)2](PF6). Following the procedure described for [Ru-
(4a)(bpy-d8)2](PF6), a mixture of 2-(2′-pyrrolyl)-[1,8]-naphthyridine
(5bH, 59 mg, 0.3 mmol) and [Ru(bpy-d8)2Cl2] (161 mg, 0.3 mmol) in
EtOH/H2O (3:1, 20 mL) was heated at reflux for 24 h to afford the
complex as a brown red solid (20 mg, 13%): 1H NMR (CD3CN) δ
7.96 (dd, 1H, J ) 8.7 Hz, 1.8 Hz, H5), 7.91 (d, 1H, J ) 8.7 Hz, H4),
7.80 (dd, 1H, J ) 4.5 Hz, 1.8 Hz, H7), 7.77 (d, 1H, J ) 8.7 Hz, H3),
7.13 (dd, 1H, J ) 3.9 Hz, 0.9 Hz, H3′), 7.08 (q, 1H, H6), 6.23 (q, 1H,
H4′), 6.02 (q, 1H, H5′).
1
(1.14 g, 87%): mp 135-137 °C; H NMR (CDCl3) δ 9.66 (s, 1H,
NH), 9.07 (d, 1H, J ) 2.1 Hz, H2′), 8.75 (dd, 1H, J ) 3.9 Hz, 1.2 Hz,
H6′ or H2), 8.54 (dd, 1H, J ) 5.1 Hz, 1.2 Hz, H2 or H6′), 8.19 (dd, 1H,
J ) 8.1 Hz, 1.5 Hz, H4 or H4′), 8.11 (dd, 1H, J ) 8.1 Hz, 0.9 Hz, H4′
or H4), 7.72 (d, 1H, J ) 7.5 Hz, H5), 7.51 (t, 1H, J ) 8.1 Hz, H6), 7.40
(dd, 1H, H5′ or H3), 7.32 (dd, 1H, H3 or H5′), 7.27 (d, 1H, J ) 8.1 Hz,
H7), 2.42 (s, 3H, CH3).
2-(3′-Pyridyl)-pyrrolo[3,2-h]quinoline (6cH). Following the pro-
cedure described for 6bH, the hydrazone 13c (1.02 g, 3.9 mmol) was
treated with PPA (10 g) at 120-130 °C for 2 h to provide 6cH as an
1
off-white solid (0.82 g, 86%): mp 181-183 °C; H NMR (CDCl3) δ
11.10 (s, 1H, NH), 9.06 (s, 1H, H2′), 8.74 (d, 1H, J ) 4.2 Hz, H8),
8.54 (d, 1H, J ) 4.2 Hz, H6′), 8.26 (d, 1H, J ) 8.1 Hz, H6), 7.98 (d,
1H, J ) 7.2 Hz, H4′), 7.81 (d, 1H, J ) 8.4 Hz, H4 or H5), 7.48 (d, 1H,
J ) 8.7 Hz, H5 or H4), 7.36 (dd, 1H, H7), 7.29 (dd, 1H, H5′), 7.06 (s,
1H, H3). Anal. Calcd for C16H11N3‚0.5H2O: C, 75.59; H, 4.72; N, 16.54.
Found: C, 75.89; H, 4.76; N, 16.48; MS m/z 245 (M+).
2-[3′-(1-Methylpyridyl)]-pyrrolo[3,2-h]quinolinium iodide (14aH).
The 2-(3′-pyridyl)-pyrrolo[3,2-h]quinoline (0.30 g, 1.2 mmol) was
dissolved in CH3CN (20 mL) with heating. Excess CH3I (1.5 g, 10.6
mmol) was added, and the mixture was heated at reflux for 30 min.
After cooling, 14aH was obtained as a yellow solid (0.33 g, 70%):
1
mp 220-223 °C; H NMR (DMSO-d6) δ 13.10 (s, 1H, NH), 9.70 (s,
1H, H2′), 9.14 (d, 1H, J ) 8.4 Hz, H4′), 8.92 (d, 1H, J ) 4.2 Hz, H8),
8.83 (d, 1H, J ) 6.0 Hz, H6′), 8.42 (d, 1H, J ) 8.4 Hz, H6), 8.17 (dd,
1H, H5′), 7.84 (d, 1H, J ) 8.7 Hz, H4 or H5), 7.57 (d, 1H, J ) 8.7 Hz,
H5 or H4), 7.57-7.54 (m, overlapping, 2H, H3 and H7), 4.39 (s, 3H,
CH3). Anal. Calcd for C17H14N3I: C, 52.71; H, 3.62; N, 10.85. Found:
C, 52.33; H, 3.62; N, 10.60; MS m/z 259 (M-1+).
8-Quinolylhydrazone of 4-acetylpyridine (13d). Following the
procedure described for 13b, a mixture of 8-hydrazinoquinoline (0.80
g, 5 mmol), 4-acetylpyridine (0.60 g, 0.5 mmol), and HOAc (2 drops)
in EtOH (25 mL) was heated at reflux for 4 h to provide 13d as a
1
yellow solid (1.22 g, 93%): mp 151-152 °C; H NMR (CDCl3) δ
9.81 (s, 1H, NH), 8.78 (dd, 1H, J ) 3.6 Hz, 0.9 Hz, H2), 8.61 (d, 2H,
J ) 6.0 Hz, H2′ and H6′ ), 8.14 (d, 1H, J ) 8.4 Hz, H5 or H4), 7.77 (m,
overlapping, 3H, H3′, H5′ and H4 or H5), 7.54 (t, 1H, J ) 7.8 Hz, H6),
7.43 (t, 1H, H3), 7.33 (d, 1H, J ) 8.1 Hz, H7), 2.41 (s, 3H, CH3).
2-(4′-Pyridyl)-pyrrolo[3,2-h]quinoline (6dH). Following the pro-
cedure described for 6bH, the hydrazone 13d (0.66 g, 2.5 mmol) was
treated with PPA (10 g) at 120 °C for 2 h to afford 6dH as a brown-
gray solid (0.55 g, 90%): mp 218-219 °C; 1H NMR (CDCl3) δ 11.19
(s, 1H, NH), 8.75 (dd, 1H, J ) 4.2 Hz, 1.2 Hz, H8), 8.59 (d, 2H, J )
5.7 Hz, H2′ and H6′), 8.26 (dd, 1H, J ) 8.1 Hz, 1.2 Hz, H6), 7.80 (d,
1H, J ) 8.4 Hz, H5 or H4), 7.58 (d, 2H, J ) 6.0 Hz, H3′ and H5′), 7.48
(d, 1H, J ) 8.7 Hz, H4 or H5), 7.39 (dd, 1H, H7), 7.18 (s, 1H, H3); 13
C
NMR (CDCl3) δ 150.4, 148.1, 139.2, 137.9, 136.8, 134.6, 132.4, 127.8,
[Ru(16)(bpy-d8)2](PF6)2. Following the procedure described for [Ru-
(4a)(bpy-d8)2](PF6), a mixture of 2-(2′-pyridyl)-quinoline (16, 21 mg,
0.1 mmol) and [Ru(bpy-d8)2Cl2] (54 mg, 0.1 mmol) in EtOH/H2O (3:
1, 20 mL) was heated at reflux for 24 h to afford the complex38,39 as
a brown red solid (20 mg, 22%): 1H NMR (CD3CN) δ 8.70 (d, 1H, J
) 8.1 Hz, H3′), 8.54 (AB quartet, 2H, H3 and H4), 8.13 (t, 1H, J ) 7.8
Hz, H4′), 8.00 (d, 1H, J ) 8.1 Hz, H5), 7.62 (d, 1H, J ) 5.7 Hz, H6′),
7.59 (t, 1H, J ) 7.8 Hz, H6), 7.43 (d, 1H, J ) 7.5 Hz, H8), 7.40 (t, 1H,
J ) 7.2 Hz, H5′), 7.26 (t, 1H, J ) 7.8 Hz, H7); MS m/z 317 (M - 1+).
[Ru(6a)(bpy-d8)2](PF6). A mixture of pyrrolo[3,2-h]quinoline (6aH,
51 mg, 0.3 mmol), [Ru(bpy-d8)2Cl2] (161 mg, 0.3 mmol), and Et3N (2
drops) in EtOH/H2O (4:1, 25 mL) was heated at reflux for 20 h under
Ar. After cooling, a solution of NH4PF6 (326 mg, 2 mmol) in H2O (5
mL) was added. H2O (50 mL) was added, and a precipitate formed.
The brown solid was collected by filtration and purified by chroma-
tography on alumina (25 mg). The first fraction eluted with CH2Cl2
provided unreacted ligand. The second fraction eluted with CH2Cl2/
125.8, 121.8, 120.4, 119.9, 119.1, 103.8; MS m/z 245 (M+).
2-[4′-(1′-Methylpyridyl)]-pyrrolo[3,2-h]quinolinium iodide (14bH).
A mixture of 2-(4′-pyridyl)-pyrrolo[3,2-h]quinoline (0.20 g, 0.8 mmol)
and CH3I (1.00 g, 7.0 mmol) in CH3CN was stirred for 10 min at 45
°C. The salt 14bH was obtained as a yellow solid (0.20 g, 65%): mp
1
> 300 °C; H NMR (DMSO-d6) δ 13.36 (s, 1H, NH), 8.94 (d, 1H, J
) 3.3 Hz, H8), 8.87 (d, 2H, J ) 6.6 Hz, H2′ and H6′), 8.65 (d, 2H, J )
6.9 Hz, H3′ and H5′), 8.43 (d, 1H, J ) 7.5 Hz, H6), 7.87 (s, 1H, H3),
7.83 (d, 1H, J ) 8.7 Hz, H4 or H5), 7.61 (dd, 1H, H7), 7.59 (d, 1H, J
) 9.0 Hz, H5 or H4), 4.23 (s, 3H, CH3); 13C NMR (DMSO-d6) δ 148.7,
145.6, 145.0, 138.0, 136.6, 135.3, 131.5, 127.1, 126.4, 121.7, 121.3,
121.2, 121.1, 109.9, 46.7. Anal. Calcd for C17H14N3I‚H2O: C, 50.37;
H, 3.95; N, 10.37. Found: C, 50.01; H, 3.70; N, 10.05; MS m/z 259
(M-1+).
2-[4′-(1′-Methylpyridinylidene)]-2H-pyrrolo[3,2-h]quinoline (15).
A mixture of 2-[4′-(1′-methylpyridyl)]-pyrrolo[3,2-h]quinolinium iodide
(150 mg, 0.4 mmol) and sodium acetate (2.0 g) in water (40 mL) was
heated until it dissolved completely. After cooling to room temperature,
ammonium hydroxide (20 mL) was added, and the solution was stirred
for 10 min. The solution was then extracted with CH2Cl2 (3 × 50 mL).
(38) Thummel, R. P.; Decloitre, Y. Inorg. Chim. Acta 1987, 128, 245.
(39) Anderson, S.; Seddon, K. R.; Wright, R. D.; Cocks, A. T. Chem. Phys.
Lett. 1980, 71, 220.